- Sirona Medical, headquartered in San Francisco, California, provides a cloud-native platform for radiology that integrates imaging, reporting, and AI-powered workflows, positioning itself as a leader in modernizing radiology infrastructure.
- In October 2025, Sirona Medical received FDA 510(k) clearance for its Advanced Imaging Suite, enhancing its capabilities to include PET-CT support, which marks a significant regulatory milestone for the company.
- Sirona has partnered with Nucleai to deliver an integrated spatial proteomics solution aimed at pharmaceutical and biotechnology companies, facilitating applications in oncology, immunology, and neuroscience.
- The ideal buyers for Sirona Medical are healthcare institutions and radiology departments seeking to streamline workflows and improve diagnostic efficiency, particularly as the demand for remote and advanced imaging solutions continues to grow.
Sirona Medical's workforce is organized into ten departments, with Engineering leading at 13 employees, followed closely by Operations with 11. Information Technology comprises 7 staff members, while Sales and Executive departments have 5 and 4 employees, respectively. The distribution reflects a strong emphasis on technical and operational capabilities, supporting the company's software development focus. Additionally, the presence of smaller teams in Community and Social Services, Marketing, and Human Resources indicates a balanced approach to both internal and external engagement.
The company's workforce is distributed across 24 locations, with the highest concentration in San Francisco, CA, housing 8 employees. Burlington, MA, and Salt Lake City, UT, follow with 3 and 2 employees, respectively. The significant number of employees categorized under 'Other' suggests a broad remote or distributed workforce strategy, enabling flexibility and access to diverse talent pools. Overall, the geographic distribution supports operational efficiency while maintaining a strong presence in key markets.
